A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2002
10/22/2002	US6468993 Method for reducing development of osteoporosis
10/22/2002	US6468992 Phosphonic acid diester derivatives
10/22/2002	US6468991 Method of treating rhinoviral infections
10/22/2002	US6468990 Method of inhibiting binding of nerve growth factor to p75 NTR receptor
10/22/2002	US6468989 Gel compositions containing metronidazole
10/22/2002	US6468986 Composition comprising polynucleotide and polycationic agent which exhibits net positive electrical charge at physiological ph, and is capable of mediating entry of polynucleotides into cell
10/22/2002	US6468983 RNase L activators and antisense oligonucleotides effective to treat telomerase-expressing malignancies
10/22/2002	US6468980 Composition comprising cancer chemotherapeutic agent and potentiating agent selected from group consisting of vitamin c metabolites or ascorbic acid-derived furanones
10/22/2002	US6468977 Compounds useful in treatment treatment of disorder and/or disease caused by activity of enzymes such as human rhinovirus 3c protease, transglutaminase and cathepsins
10/22/2002	US6468975 Glucocorticoid receptor antagonists that are preferably liver selective and are useful in treatment of diabetes
10/22/2002	US6468971 Maintaining kidney function during surgery or trauma
10/22/2002	US6468967 Methods for administration of antibiotics
10/22/2002	US6468966 Octacyclodepsipeptides having an endoparasiticidal action
10/22/2002	US6468965 Pharmaceutical composition for oral administration of a mixture of chelating agents
10/22/2002	US6468963 Methods and formulations for reducing toxicity associated with diabetes treatments
10/22/2002	US6468962 Nutritional intervention composition for enhancing and extending satiety
10/22/2002	US6468960 Therapeutic compositions and methods for enhancing angiogenesis
10/22/2002	US6468798 Liposome-nucleic acid complexes are prepared then delivered via aerosol to the lung airway; for transforming pulmonary cells and treating lung diseases
10/22/2002	US6468756 Methods of identifying compounds that bind to SNORF25 receptors
10/22/2002	US6468737 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders
10/22/2002	US6468562 Fluidity improver and/or anti-agglomeration agent, and a hydrophobic, moisture-proof layer is arranged on the surface of the particles; use in animal feeds, cosmetics and drugs
10/22/2002	US6468560 Controlled release dosage form of [R-(Z)]-α-(methoxyimino)-α-(1-azabicyclo[2.2.2]oct-3yl) acetonitrile monohydrochloride
10/22/2002	US6468559 Conditions associated with bone resorption such as osteoporosis, paget's disease, periprosthetic bone loss, osteolysis, malignant hypercalcemia, metastatic bone disease, multiple myeloma, and periodontal disease
10/22/2002	US6468556 Administering conjugated linoleic acid, cla
10/22/2002	US6468549 Gelling or thickening a cosmetic or dermatological composition
10/22/2002	US6468548 Autoclavable pharmaceutical compositions containing a chelating agent
10/22/2002	US6468546 Compositions and methods for therapy and diagnosis of ovarian cancer
10/22/2002	US6468539 Protein targeting into HIV virions based on HIV-1 VPR fusion molecules
10/22/2002	US6468533 Polyclonal or monoclonal antibody that inhibits high mobility group 1 protein mediated activation of inflammatory cytokine cascade; sepsis
10/22/2002	US6468527 Biological bioadhesive composition and methods of preparation and use
10/22/2002	US6468519 Polyanhydrides with biologically active degradation products
10/22/2002	US6468508 Method, apparatus, and composition for automatically coating the human body and skin preconditioning system for use therewith
10/22/2002	US6468507 Non-aqueous aerosol formulation comprising rosiglitazone maleate, a non-aqueous carrier, and an amino acid stabilizer
10/22/2002	US6468504 Composition comprising methylphenidate and another drug
10/22/2002	US6468503 Method and composition for the treatment of cancer by the enzymatic conversion of soluble radioactive toxic precipitates in the cancer
10/22/2002	CA2406976A1 Active substance combination containing an opioid having a fentanyl-type structure and ketamine
10/22/2002	CA2291129C Method for the preparation of citalopram
10/22/2002	CA2253914C Camptothecin-skeleton compounds isolated from mappia foetida and the use thereof as syntones for novel medicaments as well as therapeutical agents
10/22/2002	CA2218477C Rna photocleavage using texaphyrins
10/22/2002	CA2212904C The activity-inhibitor and activity-potentiator for glutamic acid in the brain
10/22/2002	CA2118670C Pharmaceutical compositions in semisolid form and a device for administration thereof
10/22/2002	CA2084093C Composite molecular system for the contra-escalatory treatment of viral infections
10/22/2002	CA2073084C The use of sulphur-containing carboxylic acids to combat physiologically-induced excitatory disorders and diseases related thereto as well as allergic diseases and also the preparation of corresponding medicaments
10/20/2002	CA2382326A1 Therapeutic use of selective pde10 inhibitors
10/20/2002	CA2380211A1 Compositions for controlling microorganisms, comprising primary and secondary esters of polyglycerol in an effective ratio
10/20/2002	CA2380210A1 Compositions for controlling microorganisms, comprising an effective content of enzymatically prepared esters of polyglycerol
10/17/2002	WO2002082462A2 Stabilization and terminal sterilization of phospholipid formulations
10/17/2002	WO2002082091A2 Method for identification of proteins from intracellular bacteria
10/17/2002	WO2002082075A2 Method for detecting chronic dementia diseases, and corresponding peptides and detection reagents
10/17/2002	WO2002082074A1 Intranasal delivery of agents for regulating development of implanted cells in the cns
10/17/2002	WO2002082044A2 Method of imaging cell death in vivo
10/17/2002	WO2002081754A1 Nucleic acid vaccines for prevention of flavivirus infection
10/17/2002	WO2002081751A2 A method of increasing endogenous leptin production
10/17/2002	WO2002081747A1 Method of examining steroid responsiveness
10/17/2002	WO2002081728A2 Quinoline inhibitors of hyak1 and hyak3 kinases
10/17/2002	WO2002081677A2 Improved gene expression
10/17/2002	WO2002081668A2 Desaturase genes and uses thereof
10/17/2002	WO2002081665A2 Implantation serine proteinases
10/17/2002	WO2002081664A2 Use of nucleosides, nucleobases and derivatives thereof for improved production of adult stem cells
10/17/2002	WO2002081661A2 Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides
10/17/2002	WO2002081651A2 Polyphenolics for enhancing endothelial cell-mediated fibrinolysis
10/17/2002	WO2002081649A2 ErbB INTERFACE PEPTIDOMIMETICS AND METHODS OF USE THEREOF
10/17/2002	WO2002081619A1 Glycosaminoglycan/collagen complexes and use thereof
10/17/2002	WO2002081528A1 Polymer specifically recognizing bile acid, process for producing the same, bile acid-absorbing polymer and cholesterol-lowering agents
10/17/2002	WO2002081518A2 Proteins, polynucleotides encoding them and methods of using the same
10/17/2002	WO2002081508A2 Use of cd25 binding molecules in steroid-resistant patients
10/17/2002	WO2002081496A2 Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours
10/17/2002	WO2002081494A1 Oligonucleotide mediated inhibition of hepatitis b virus and hepatitis c virus replication
10/17/2002	WO2002081493A1 9-amino-14-membered macrolide derived from leucomycin
10/17/2002	WO2002081484A1 Tumour inhibiting gallium compounds
10/17/2002	WO2002081482A1 Compounds and methods for inhibiting mrp1
10/17/2002	WO2002081481A1 Compounds and methods for inhibiting mrp1
10/17/2002	WO2002081480A1 Compounds and pharmaceutical compositions for inhibiting mrp1
10/17/2002	WO2002081478A2 Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide hiv protease inhibitors
10/17/2002	WO2002081477A1 7-substituted morphinane derivatives and medicinal use thereof
10/17/2002	WO2002081475A1 Jun kinase inhibitors
10/17/2002	WO2002081471A1 Beta-carboline derivatives and its pharmaceutical use against depression and anxiety
10/17/2002	WO2002081470A1 Oxazolidinones containing a sulfonimid group as antibiotics
10/17/2002	WO2002081467A1 Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders
10/17/2002	WO2002081464A1 Benzoaxathiepin derivatives and their use as medicines
10/17/2002	WO2002081463A1 Antagonists of mcp-1 function and methods of use thereof
10/17/2002	WO2002081461A1 Piperazine derivatives as tachykinin antagonists
10/17/2002	WO2002081460A1 Lipid lowering biphenylcarboxamides
10/17/2002	WO2002081457A1 `1,4!-diazepane-1-carboxylic acid derivatives process for their preparation and their use as tachykinin antagonists
10/17/2002	WO2002081456A1 Cyanamide, alkoxyamino, and urea derivatives of 4, 4-disubstituted-3, 4-dihydro-2 (1h)- quinazolinones as hiv reverse transcriptase inhibitors
10/17/2002	WO2002081453A1 Thiohydantoins and use thereof for treating diabetes
10/17/2002	WO2002081449A1 Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors
10/17/2002	WO2002081448A1 Benzamidine derivative
10/17/2002	WO2002081445A1 Indolinones, substituted in position 6, and their use as kinase inhibitors
10/17/2002	WO2002081444A1 1-indolyl derivatives, use thereof for production of medicaments, a method for production of said 1-indolyl derivatives and pharmaceutical preparations containing 1-indolyl derivatives
10/17/2002	WO2002081443A1 Novel guanidino compounds
10/17/2002	WO2002081435A1 Sulphones which modulate the action of gamma secretase
10/17/2002	WO2002081433A1 Sulphones which modulate the action of gamma secretase
10/17/2002	WO2002081430A2 Novel benzylideneamino guanidines and their uses as ligands to the melanocortin receptors
10/17/2002	WO2002081428A1 Benzene compound and salt thereof
10/17/2002	WO2002081426A1 Peptide deformylase inhibitors
10/17/2002	WO2002081420A1 Cyclooctanone derivative and cyclodecanone derivative, and use thereof
10/17/2002	WO2002081415A2 Method for inhibiting metap2
10/17/2002	WO2002081398A2 Additives for building industry obtained from by-products and process for their production
10/17/2002	WO2002081028A2 Cytoprotection by phosphotyrosine

1 ... 5675 5676 5677 5678 5679 5680 5681 5682 5683 5684 5685 5686 5687 5688 5689 5690 5691 5692 5693 5694 5695 ... 7860